Atropine Sulphate Injection

Name: Atropine Sulphate Injection
Brand: Artemisine Medicines Technology Co., Ltd.

Injection

Atropine Sulphate Injection

Atropine Sulphate Injection — GMP manufactured injection by Artemisine Medicines Technology. Original manufacturer supply with stable quality, factory direct price and full batch documentation for global markets.

Product Name	Atropine Sulphate Injection
Dosage Form	Injection
Strength	As per BP monograph / enterprise standard
Standards	BP / ENTERPRISE
Packing	Customized per market requirement (bottle / blister / box)
Documents	COA, COPP, DMF, CTD Dossiers
MOQ	Contact us for MOQ and current stock

Request Quotation › ← Back to Injection

WHO Prescribing Guidance

Indications · Administration · Dosage · Precautions

Reference information summarised from WHO prescribing guidance. Expand each item below — clinical use must always follow the locally approved product insert.

🎯Indications▾

Symptomatic bradycardia and AV block, organophosphate and carbamate poisoning (WHO essential antidote), pre-anaesthetic antisialagogue and antidote for cholinergic excess.

💧Administration▾

Intravenous (or intramuscular if no IV access) injection; in poisoning, large cumulative doses may be required until secretions dry.

⚖️Dosage▾

Bradycardia: adults 0.5–1 mg IV every 3–5 min, maximum 3 mg total; children 0.02 mg/kg (min 0.1 mg). Organophosphate poisoning: adult initial 1–2 mg IV/IM, doubled every 5–10 min until atropinisation (paediatric 0.05 mg/kg).

⚠️Precautions & Warnings▾

Anticholinergic effects: dry mouth, mydriasis, urinary retention, tachycardia and confusion. Caution in glaucoma, prostatic hypertrophy and tachyarrhythmia. Never use for organophosphate poisoning without adequate dosing titrated to clinical endpoints.

Reference: WHO Model Formulary / WHO Model List of Essential Medicines. For professional reference only — clinical use must follow the locally approved product insert and national treatment guidelines.

Why Order From Us

Factory Direct. Fully Documented.

🛡️

GMP Quality

Full batch testing and quality traceability under standard GMP workshops.

🚢

Fast Delivery

Sufficient stock on regular items, familiar with export logistics to 50+ countries.

📑

Registration Support

COA, DMF, dossier and legalization documents for your market registration.

FAQ

Atropine Sulphate Injection — Frequently Asked Questions

Which documents are provided for Atropine Sulphate Injection registration?

Every batch of Atropine Sulphate Injection ships with a Certificate of Analysis (COA). For market registration we provide COPP, DMF and CTD-format dossiers, plus legalisation support where your authority requires it.

What is the MOQ and lead time for Atropine Sulphate Injection?

MOQ and lead time for Atropine Sulphate Injection depend on strength, packaging and destination market. Send us your target market and annual volume — our export team confirms current stock, MOQ and lead time within 24 hours.

Do you support OEM / private label?

Yes. We offer OEM packaging and private-label production for Atropine Sulphate Injection, subject to the regulatory requirements of the destination market.

Which markets have you exported injection products to?

We have supplied injection products to 50+ countries across Africa, Southeast Asia, Latin America and the Middle East, with experience in ministry-of-health registration and international tenders.

How is the quality of Atropine Sulphate Injection controlled?

Atropine Sulphate Injection is produced in China-GMP workshops (site re-inspected and passed in 2026), released only after full QC testing against BP / enterprise standards, with retained samples kept for one year beyond the product's expiry date.

Ask About This Product ›